Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP   3:59:53 PM EDT
2.21
+0.29 (+15.10%)
4:37:17 PM EDT: $2.21 0.00 (0.00%)
Earnings Announcements

Tonix Pharmaceuticals Reports First Quarter 2022 Financial Results And Operational Highlights

Published: 05/09/2022 13:45 GMT
Tonix Pharmaceuticals Holding Corp (TNXP) - Tonix Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights.
Tonix Pharmaceuticals Holding - Cash and Cash Equivalents Totaled About $140 Million at March 31, 2022.
Tonix Pharmaceuticals Holding Corp - Net Loss per Common Share Was $0.05 per Share, Basic and Diluted, for Q1 of 2022.
Tonix Pharmaceuticals Holding - As of March 31, 2022, Tonix Had $140.4 Million of Cash and Cash Equivalents.